BALYASNY ASSET MANAGEMENT L.P. - TRILLIUM THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 116 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.6%.

Links
Filings
Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$16,192,000
+386.7%
922,100
+293.9%
0.07%
+179.2%
Q3 2020$3,327,000
+152.6%
234,122
-28.2%
0.02%
+50.0%
Q1 2020$1,317,000–326,065–0.02%–
 Download
Other shareholders

There were no reported owners of TRILLIUM THERAPEUTICS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of TRILLIUM THERAPEUTICS INC shareholders